Evidence map›Paper›PMID 40146341›Full record

Trial reportWorld journal of urology2025

Association of energy source with outcomes in en bloc TURB: secondary analysis of a randomized trial.

Stefano Mancon, Francesco Soria, Rodolfo Hurle, Dmitry Enikeev, Evanguelos Xylinas, Lukas Lusuardi, Axel Heidenreich, Paolo Gontero, Eva Compérat, Shahrokh F Shariat and 2 more

Registry-linked trialAbstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03718754 (En-bloc vs Conventional Resection of Primary Bladder Tumor), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03718754 phase3completednot on this map

En-bloc vs Conventional Resection of Primary Bladder Tumor: Prospective Randomized Multicenter Trial

TypeinterventionalSponsorDavid D'AndreaRan2019 to 2021Enrolled384ConditionsBladder CancerArmsEn-Bloc TURB, Conventional TURB
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stefano ManconDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Francesco SoriaDepartment of Urology, AOU Città della Salute e della Scienza, Torino School of Medicine, Turin, Italy.
Rodolfo HurleDepartment of Urology, IRCCS Humanitas Research Hospital, Milan, Italy.
Dmitry EnikeevDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Evanguelos XylinasDepartment of Urology, Bichat Claude Bernard Hospital, Paris Cité University, Paris, France.
Lukas LusuardiDepartment of Urology and Andrology, Paracelsius Medical University, Salzburg, Austria.
Axel HeidenreichDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Paolo GonteroDepartment of Urology, AOU Città della Salute e della Scienza, Torino School of Medicine, Turin, Italy.
Eva CompératDepartment of Pathology, Medical University of Vienna, Vienna, Austria.
Shahrokh F ShariatDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
David D'AndreaDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. david.dandrea@muv.ac.at.
eBLOC Study Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo comprehensively evaluate the efficacy of different energy sources used for en-bloc transurethral resection of bladder tumors (ERBT) on perioperative outcomes.

methodsThis sub-analysis derived from a prospective randomized study that enrolled patients undergoing ERBT vs conventional transurethral resection of the bladder (cTURB) from January 2019 to January 2022 (NCT03718754). Endpoints were pathological specimen quality and perioperative outcomes after either monopolar (m-ERBT) or bipolar (b-ERBT) or laser (l-ERBT) ERBT.

results237 bladder tumors resected in 188 patients included in the analyses: 29 (12.2%) m-ERBT, 136 (57.4%) b-ERBT and 72 (30.4%) l-ERBT. Detrusor muscle (DM) was detected in 191 (80.6%) specimens. Per-tumor analysis revealed comparable rate of DM in the specimens obtained via different energy modalities (p = 0.7). Operative time was longer in the l-ERBT cohort compared to m-ERBT and b-ERBT (p = 0.02) and no obturator nerve reflex (ONR) onset was reported. On logistic regression analysis, b-ERBT was associated with negative lateral resection margins (OR 2.81; 95% CI 1.02-7.70; p = 0.04). There was no significant association of the resection technique with perforation and conversion rates (all p > 0.05). Within a median follow up of 22mo (IQR 11-29), a total of 35 (18.6%) patients had a local recurrence. On Cox regression analysis, patients resected with b-ERBT were less likely to have a recurrence (HR 0.34; 95% CI 0.15-0.78; p = 0.01); When adjusting for established confounders, this association was confirmed (HR 0.24; 95% CI 0.10-0.60; p = 0.002).

conclusionsDifferent energy sources might achieve comparable perioperative outcomes. Further perspectives involve the assessment of long-term differential oncological outcomes associated with various energy modalities.

Indexed as

CystectomyLasers, Solid-StateLaser TherapyUrinary Bladder NeoplasmsAgedFemaleHumansMaleMiddle AgedProspective StudiesTreatment OutcomeBladder cancerDiagnosisEn blocEnergy sourceResectionTreatment

Identifiers

PMID40146341
PMCPMC11950035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.